Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
Provided By GlobeNewswire
Last update: Nov 12, 2024
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced its financial and operating results for the third quarter of 2024.
Read more at globenewswire.com
